Stay updated with breaking news from Exact Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The test, using blood or saliva, can evaluate genetic risk for colorectal, breast, prostate, skin, ovarian, endometrial, pancreatic, gastric, kidney and endocrine cancers.
Exact Sciences Co. (NASDAQ:EXAS – Get Free Report) insider Jacob A. Orville sold 1,879 shares of the company’s stock in a transaction on Tuesday, February 27th. The stock was sold at an average price of $56.89, for a total value of $106,896.31. Following the sale, the insider now owns 11,754 shares of the company’s stock, […]
MADISON, Wis. -- There is a start-up silently saving jobs – and lives - here in Madison, and you might not even know about it.
Phase 2 EDA Tech Hub Funding Application Fueled by Collaboration...
The test, using blood or saliva, can evaluate genetic risk for colorectal, breast, prostate, skin, ovarian, endometrial, pancreatic, gastric, kidney and endocrine cancers.